ReviewJournal of diabetes research2023

Research Progress on the GIP/GLP-1 Receptor Coagonist Tirzepatide, a Rising Star in Type 2 Diabetes.

Zijun Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.